Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.
Authors
Hajiev, Saur
Allara, Elias
Motedayеn Aval, Leila
Arizumi, Tadaaki
Bettinger, Dominik
Pirisi, Mario
Rimassa, Lorenza
Pressiani, Tiziana
Personeni, Nicola
Giordano, Laura
Kudo, Masatoshi
Thimme, Robert
Park, Joong-Won
Taddei, Tamar H
Kaplan, David E
Ramaswami, Ramya
Pinato, David J
Publication Date
2021-04Journal Title
Br J Cancer
ISSN
0007-0920
Publisher
Springer Science and Business Media LLC
Volume
124
Issue
9
Pages
1611-1611
Language
en
Type
Other
This Version
VoR
Metadata
Show full item recordCitation
Hajiev, S., Allara, E., Motedayеn Aval, L., Arizumi, T., Bettinger, D., Pirisi, M., Rimassa, L., et al. (2021). Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.. [Other]. https://doi.org/10.1038/s41416-020-01241-5
Abstract
<jats:p>A Correction to this paper has been published: https://doi.org/10.1038/s41416-020-01241-5</jats:p>
Keywords
Correction, /692/699/67/1059/602, /692/4028/67/1504/1610/4029, correction
Identifiers
s41416-020-01241-5, 1241
External DOI: https://doi.org/10.1038/s41416-020-01241-5
This record's DOI: https://doi.org/10.17863/CAM.81012
Rights
Licence:
http://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.